Literature DB >> 21264009

Management of arrhythmias.

C E Rotem.   

Abstract

Arrhythmias are a frequent presenting symptom requiring further investigation. Not all arrhythmias are of clinical significance, and many need not be treated. Symptomatic and frequently recurring paroxysmal atrial tachycardia, atrial fibrillation with rapid ventricular response, the changing arrhythmias of the tachycardia-bradycardia syndrome should be investigated, and most should be treated. Frequent symptomatic ventricular premature beats need occasionally be treated when they interfere with a patient's quality of life, and when they are associated with serious underlying cardiac disease. Complex and sustained ventricular arrhythmias should be treated following thorough investigation because of the risk of sudden cardiac death. The range of available therapeutic options, pharmaceutical and non-pharmaceutical, has become quite bewildering. Many new anti-arrhythmic drugs have been, and are being, developed; all still have potential pro-arrhythmic effects. New electrosurgical procedures are available, as well as new implantable anti-arrhythmic pacemakers and automatic defibrillators.

Entities:  

Year:  1987        PMID: 21264009      PMCID: PMC2218680     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  5 in total

1.  QUINIDINE SYNCOPE. PAROXYSMAL VENTRICULAR FIBRILLATION OCCURRING DURING TREATMENT OF CHRONIC ATRIAL ARRHYTHMIAS.

Authors:  A SELZER; H W WRAY
Journal:  Circulation       Date:  1964-07       Impact factor: 29.690

2.  How to approach an arrhythmia.

Authors:  L Schamroth
Journal:  Circulation       Date:  1973-02       Impact factor: 29.690

3.  Aggravation of arrhythmia induced with antiarrhythmic drugs during electrophysiologic testing.

Authors:  R F Poser; P J Podrid; F Lombardi; B Lown
Journal:  Am Heart J       Date:  1985-07       Impact factor: 4.749

4.  Reduction in sudden death and total mortality by antiarrhythmic therapy evaluated by electrophysiologic drug testing: criteria of efficacy in patients with sustained ventricular tachyarrhythmia.

Authors:  T J Waller; H R Kay; S R Spielman; S P Kutalek; A M Greenspan; L N Horowitz
Journal:  J Am Coll Cardiol       Date:  1987-07       Impact factor: 24.094

5.  Aggravation and provocation of ventricular arrhythmias by antiarrhythmic drugs.

Authors:  V Velebit; P Podrid; B Lown; B H Cohen; T B Graboys
Journal:  Circulation       Date:  1982-05       Impact factor: 29.690

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.